Proton Therapy
Proton therapy, IMRT comparably effective for low-, intermediate-risk prostate cancer
Photon and proton beam radiation therapies conferred similar outcomes for men with localized prostate cancer, according to results of a randomized phase 3 trial.
Proton Therapy and Radiation Oncology with Isabelle Choi, MD
In this episode, host Shikha Jain, MD, speaks with Isabelle Choi, MD, about the use of proton therapy in radiation oncology, improving accessibility to radiation technology and more.
Healio Minute, Breast Cancer Edition: Top Headlines for the Week of December 12, 2022
In this episode, FDA grants fast track designation to REM-001; practice-changing treatment advances continue; proton partial breast radiotherapy appears effective and more.
8 important updates for Brain Cancer Awareness Month
May is Brain Cancer Awareness Month.
As proton beam therapy use for cancer increased, ‘so did the racial disparity in receipt’
Use of proton beam therapy increased significantly among patients with cancer in the U.S. between 2004 and 2018, but Black individuals had a lower likelihood of receiving the therapy than their white counterparts.
Does proton therapy have a role in the treatment of brain tumors?
Proton therapy (PT) is a potentially important radiation modality for primary brain tumors due to its unique dose distributions. Unlike photon radiation, PT dose is characterized by a well-defined maximal range where the majority of the dose is deposited, followed by a rapid dose falloff to zero distally within a mere few millimeters.
Amid questions about cost and access, proton therapy set for ‘big moment of change’
More than 3 decades after receiving FDA approval, proton beam radiation therapy has failed to find a footing as a go-to treatment for many cancers in the United States.
National Association for Proton Therapy launches physician advisory committee
National Association for Proton Therapy created a physician advisory committee to provide advice on topics such as clinical research, patient education and insurance reimbursement.
Eight important updates for Childhood Cancer Awareness Month
September is Childhood Cancer Awareness Month.
Top in hem/onc: Hydroxychloroquine and cancer, racial disparities in care
New data showed that hydroxychloroquine combined with other COVID-19 treatments may increase the risk for mortality among patients with cancer. It was the top story in hematology/oncology last week.